Dental Doctor 2025 Annual Report: Revenue of 1.767 Billion Yuan, Comprehensive Oral Service Projects Up 37.15% Year-on-YearIssuing time:2026-04-27 11:40
Net Profit Attributable to Parent Up 26.97% / Revenue RMB 1.767 Billion / Gross Margin 51.20% DentalGoodNews|On April 27, 2026, Dental Doctor Medical Holding Group Co., Ltd. (hereinafter referred to as "Dental Doctor") released its 2025 annual report. During the reporting period, the company achieved operating revenue of RMB 1.767 billion, a year-on-year increase of 12.14%; total profit reached RMB 213 million, up 30.20% year-on-year; net profit attributable to owners of the parent company was RMB 137 million, a year-on-year increase of 26.97%. In terms of profitability, the company's overall gross margin for the reporting period was 51.20%, an increase of 3.26 percentage points from 47.94% in 2024. The company stated that in 2025, it focused on "improving quality and efficiency" as the core of its strategic execution: on one hand, it enhanced the proportion of comprehensive oral service revenue and optimized the business structure through multidisciplinary collaboration and innovative diagnostic and treatment methods; on the other hand, it promoted "full-staff participation in operations," refined the full-process cost control system, and strengthened supply chain fine management to achieve simultaneous progress in revenue growth and cost control.
In terms of business structure, in 2025, the company's comprehensive service projects generated revenue of RMB 672 million, a year-on-year increase of 37.15%; the gross margin rose to 40.62%, an increase of 9.39 percentage points year-on-year; operating costs increased by 18.42% year-on-year. In comparison, implant service projects achieved revenue of RMB 801 million, a slight year-on-year decrease of 1.74%; the gross margin increased by 3.29 percentage points year-on-year to 63.61%; operating costs decreased by 9.88% year-on-year. Orthodontic treatment service projects generated revenue of RMB 294 million, a year-on-year increase of 8.68%; the gross margin slightly increased by 0.67 percentage points year-on-year to 41.52%; operating costs increased by 7.44% year-on-year.
In terms of R&D investment, the company's R&D expenditure in 2025 was RMB 3.7998 million, a year-on-year increase of 121.06%. The R&D focus was on innovative academic basic theoretical research and the application of clinical diagnostic and treatment technologies in the dental field. As of the end of the reporting period, the company had accumulated 10 invention patents, 22 utility model patents, and 5 software copyrights. Additionally, the company collaborated with an external AI data platform to create an AI decision-making platform, providing data synergy support for medical management decision-making.
In terms of cash flow performance, during the reporting period, the net cash flow generated from the company's operating activities was RMB 308 million, a year-on-year increase of 15.32%. The company stated that, while ensuring the safety of daily operating funds, it utilized idle self-owned funds for low-risk entrusted wealth management, with cumulative investment income reaching RMB 8.4634 million. In terms of market network layout, Dental Doctor continued to expand in the East China market. In 2025, the company added 6 new directly-operated dental institutions. As of the end of the reporting period, Dental Doctor operated 48 directly-owned institutions across 15 cities in East China, including 31 in Jiangsu Province and 17 outside Jiangsu Province. Additionally, the construction of the dental specialist headquarters hospital in Suzhou is being accelerated, with another 3 institutions in the preparatory stage. As of the end of the reporting period, the operating revenue of the company's medical institutions within Jiangsu Province was RMB 1.169 billion, accounting for 66.15%; the operating revenue of medical institutions outside Jiangsu Province was RMB 598 million, accounting for 33.85%. Looking ahead, Dental Doctor stated that it will continue to leverage its advantages in chain operation and standardization, focus on the East China region, and achieve nationwide scaled development by establishing a headquarters.
Article classification:
Industry Finance
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks.
Copyright © This Platform. Unauthorized reproduction & commercial use prohibited.
Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
|
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
|